BCL2 and hepatocellular carcinoma: miR-451a could be a promising target for HCC biotherapy as it targets MYC, MAPK1, and BCL2 genes that is actively involved in the HIF-1 signaling pathway, stem cell pluripotency-regulating signaling pathways, and cellular senescence.